바이오인포매틱스 제휴 및 라이선싱 계약(2019-2026년)

The definitive benchmark for bioinformatics dealmaking

Bioinformatics partnering is driven by data, computational platforms, and analytical capabilities, with deal structures reflecting access to algorithms, datasets, and integrated discovery technologies.

This report provides a comprehensive and structured analysis of 1230+ bioinformatics collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how bioinformatics deals are structured in practice, allowing you to:

• Benchmark comparable transactions with confidence
• Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
• Define realistic market parameters
• Clear insight into how deal terms vary by platform type, data access, and partner profile
• Support valuation and structuring decisions with evidence
• Ground internal discussions in real transaction data rather than assumptions
• Understand how leading companies approach dealmaking
• Visibility into partner behaviour and recurring deal structures across a data-intensive and technology-driven landscape
• Full visibility into deal structure and execution
• Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

• Rights granted and retained
• Development and commercialization responsibilities
• Financial structures and payment triggers
• Key contractual provisions and protections
• This level of transparency is critical to understanding how value, risk, and control are allocated within bioinformatics partnerships, particularly where data ownership, platform access, and integration into discovery workflows are key considerations.
• Designed for real-world BD and strategy use

The report is widely used to:

• Structure and benchmark data-driven and platform-based transactions
• Prepare for negotiations with well-defined market context
• Evaluate technology partners and collaboration opportunities
• Support internal strategy with robust, defensible data
• What's included
• 1230+ bioinformatics collaboration and licensing deals
• Financial terms, including upfronts, milestones, and royalties where disclosed
• Fully searchable deal directory (by company, platform, and application)
• Direct access to SEC-filed agreements and source documents
• Analysis of deal trends, key transactions, and active dealmakers
• A trusted, evidence-based reference for bioinformatics dealmaking
• Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how bioinformatics partnerships are structured, negotiated, and valued.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in bioinformatic dealmaking

• 2.1. Introduction
• 2.2. Bioinformatic deals over the years
• 2.3. Most active bioinformatic dealmakers
• 2.4. Bioinformatic deals by deal type
• 2.5. Bioinformatic deals by therapy area
• 2.6. Bioinformatic deals by industry sector
• 2.7. Deal terms for bioinformatic deals
  • 2.7.1 Bioinformatic deals headline values
  • 2.7.2 Bioinformatic deal upfront payments
  • 2.7.3 Bioinformatic deal milestone payments
  • 2.7.4 Bioinformatic royalty rates

Chapter 3 - Leading bioinformatic deals

• 3.1. Introduction
• 3.2. Top bioinformatic deals by value

Chapter 4 - Most active bioinformatic dealmakers

• 4.1. Introduction
• 4.2. Most active bioinformatic dealmakers
• 4.3. Most active bioinformatic deals company profiles

Chapter 5 - Bioinformatic contracts dealmaking directory

• 5.1. Introduction
• 5.2. Bioinformatic contracts dealmaking directory

Chapter 6 - Bioinformatic dealmaking by technology type

• Deal directory
• Deal directory - Bioinformatic deals by company A-Z
• Deal directory - Bioinformatic deals by deal type
• Deal directory - Bioinformatic deals by therapy area
• Deal type definitions
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Bioinformatic deals since 2019
• Figure 2: Active bioinformatic dealmaking activity
• Figure 3: Bioinformatic deals by deal type since 2019
• Figure 4: Bioinformatic deals by therapy area since 2019
• Figure 5: Bioinformatic deals by industry sector since 2019
• Figure 6: Bioinformatic deals with a headline value
• Figure 7: Bioinformatic deals with an upfront value
• Figure 8: Bioinformatic deals with a milestone value
• Figure 9: Bioinformatic deals with a royalty rate value
• Figure 10: Top bioinformatic deals by value since 2019
• Figure 11: Most active bioinformatic dealmakers
• Figure 12: Bioinformatic deals by technology type since 2019